ZOLPIDEM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Zolpidem, and what generic alternatives are available?
Zolpidem is a drug marketed by Almatica, Actavis Elizabeth, Actavis Labs Fl Inc, Apotex, Breckenridge, Lupin Ltd, Ph Health, Sandoz, Sun Pharm, Synthon Pharms, Acme Labs, Apotex Inc, Aurobindo Pharma, Chartwell Molecular, Hikma, Invagen Pharms, Mylan Pharms Inc, Rising, Senores Pharms, Strides Pharma, Strides Pharma Intl, Sun Pharm Inds Inc, Sun Pharm Inds Ltd, Sun Pharm Industries, Teva, Torrent Pharms, Watson Labs, Wockhardt, Yung Shin Pharm, Dr Reddys, Novel Labs Inc, and Pharmobedient. and is included in thirty-six NDAs.
The generic ingredient in ZOLPIDEM is zolpidem tartrate. There are thirty-three drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the zolpidem tartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Zolpidem
A generic version of ZOLPIDEM was approved as zolpidem tartrate by ACME LABS on April 23rd, 2007.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ZOLPIDEM?
- What are the global sales for ZOLPIDEM?
- What is Average Wholesale Price for ZOLPIDEM?
Summary for ZOLPIDEM
| US Patents: | 0 |
| Applicants: | 32 |
| NDAs: | 36 |
| Drug Prices: | Drug price information for ZOLPIDEM |
| Drug Sales Revenues: | Drug sales revenues for ZOLPIDEM |
| DailyMed Link: | ZOLPIDEM at DailyMed |
